ACTIVE

DEVANTHINIC PHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

888,6 k €

-9.6% YoY

Gross margin

1,3 M €

-5.5% YoY

Equity

7,7 M €

+13.0% YoY

Workforce

8,4 ETP

+25.4% YoY

What does DEVANTHINIC PHARMA do?

DEVANTHINIC PHARMA is a Private limited company incorporated in 2014. Its main activity is: Activities of holding companies. Its registered office is in Seneffe. It employs on average 8,4 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0506.893.294

Incorporation

16/12/2014

Legal form

Private limited company

Registered office

Rue des Canadiens 24
7180 Seneffe · WallonieSee on map

Contributed capital

150 000,00 €

Latest accounts

31/12/2025

Average workforce

8,4 ETP

Activities (NACE)

64200Activities of holding companies· main 64210Activities of holding companies 82990Other business support service activities n.e.c.82990Other business support service activities n.e.c.

Joint committees (3)

Signals

ProfitableSolid equityLow riskPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 11 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015
Income statement
Gross margin	1,3 M €	-5.5%	1,4 M €	+13.3%	1,2 M €	+2.0%	1,2 M €	+29.9%	930,2 k €	+79.6%	517,8 k €	+36.5%	379,2 k €	+16.4%	325,9 k €	+19.2%	273,3 k €	+150%	109,3 k €	+220%	34,2 k €
EBITDA	887,9 k €	-13.7%	1 M €	+8.6%	947,7 k €	-2.7%	973,5 k €	+12.9%	862,1 k €	+73.1%	498,1 k €	+31.4%	379,2 k €	+16.4%	325,9 k €	+19.2%	273,3 k €	+150%	109,3 k €	+220%	34,2 k €
Operating result	703,7 k €	-14.1%	818,9 k €	-13.2%	943,3 k €	-2.8%	970,8 k €	+14.6%	847,2 k €	+75.2%	483,5 k €	+32.6%	364,6 k €	+147%	147,7 k €	-42.9%	258,7 k €	+137%	109,3 k €	+220%	34,2 k €
Net result	888,6 k €	-9.6%	983,2 k €	+53.2%	642 k €	-63.4%	1,8 M €	+113%	825,1 k €	+19.3%	691,5 k €	+69.8%	407,3 k €	-67.8%	1,3 M €	+1787%	67,1 k €	+60.9%	41,7 k €	+166%	15,7 k €
Balance sheet
Equity	7,7 M €	+13.0%	6,8 M €	+16.8%	5,9 M €	+12.3%	5,2 M €	+50.7%	3,5 M €	+31.3%	2,6 M €	+35.5%	1,9 M €	+26.4%	1,5 M €	+461%	274,5 k €	+32.4%	207,4 k €	+25.2%	165,7 k €
Total assets	16,8 M €	+0.8%	16,7 M €	+6.9%	15,6 M €	+8.5%	14,4 M €	+3.0%	14 M €	+46.0%	9,6 M €	+18.0%	8,1 M €	+7.5%	7,5 M €	+21.2%	6,2 M €	+28.5%	4,8 M €	+432%	910,1 k €
Cash	351,4 k €	-24.0%	462,4 k €	+117%	213,3 k €	-46.8%	401,3 k €	+40.5%	285,6 k €	+187%	99,5 k €	-77.8%	449,2 k €	+872%	46,2 k €	+82.2%	25,4 k €	+476%	4,4 k €	+1.6%	4,3 k €
Debts	8,7 M €	-9.7%	9,6 M €	-1.2%	9,8 M €	+6.3%	9,2 M €	-12.7%	10,5 M €	+51.6%	6,9 M €	+12.4%	6,2 M €	+2.7%	6 M €	+0.9%	6 M €	+28.4%	4,6 M €	+523%	744,4 k €
Other
Workforce	8,4 ETP	+25.4%	6,7 ETP	+11.7%	6,0 ETP	+22.4%	4,9 ETP	+277%	1,3 ETP	+160%	0,5 ETP		–		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 1 ended

Active mandates

Anne André

Director · since 18 décembre 2014

Active

Ended mandates

ANNE ANDRE

Manager · since 18 décembre 2014

Ended

At this address

Other companies at this address

Company	CBE no.
DEVANTHINIC IMMO● Active	1039.753.688
MARIEC.C-PHARMA● Active	0507.640.788
PHAMALIMO● Active	0846.675.386
PHARMACIE ANNE ANDRE● Active	0478.484.667
PHARMACIE DE BASCOUP● Active	0458.492.472
PHARMACIE DE BOIS-D'HAINE● Active	0432.058.190
PHARMACIE DE LA DRÊVE● Active	0421.582.883
PHARMACIE DE LA GRAND RUE● Active	0846.815.047
PHARMACIE DE LA VILLE BASSE● Active	0872.063.652
PHARMACIE SENEFFE CENTRE● Active	0477.710.053
PHARMA-LOUVE● Active	0894.160.549

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	27/08/2026	29/08/2025	26/08/2024	31/07/2023	26/08/2022	30/08/2021
General meeting	31/07/2026	31/07/2025	31/07/2024	30/06/2023	26/05/2022	27/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

11 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	31/07/2026	27/08/2026	French	PDF
Abridged model	31/12/2024	31/07/2025	29/08/2025	French	PDF
Abridged model	31/12/2023	31/07/2024	26/08/2024	French	PDF
Abridged model	31/12/2022	30/06/2023	31/07/2023	French	PDF
Abridged model	31/12/2021	26/05/2022	26/08/2022	French	PDF
Abridged model	31/12/2020	27/05/2021	30/08/2021	French	PDF
Micro model	31/12/2019	28/05/2020	26/10/2020	French	PDF
Micro model	31/12/2018	31/05/2019	09/09/2019	French	PDF
Micro model	31/12/2017	31/05/2018	02/08/2018	French	PDF
Abridged model	31/12/2016	26/05/2017	08/08/2017	French	PDF
Abridged model	31/12/2015	26/05/2016	17/08/2016	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 1 ended

Active mandates

Anne André

Director · since 18 décembre 2014

Active

Ended mandates

ANNE ANDRE

Manager · since 18 décembre 2014

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Other29/11/2021
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE
PDF
Restructuring27/07/2018
CAPITAL, ACTIONS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Restructuring16/05/2018
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Mandates27/10/2017
DEMISSIONS, NOMINATIONS
PDF
Other21/02/2017
DIVERS
PDF
Mandates07/02/2017
DEMISSIONS, NOMINATIONS
PDF
Mandates08/04/2015
DEMISSIONS, NOMINATIONS
PDF
Other18/12/2014
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025888,6 k €↓
2024
Annual accounts 2024983,2 k €↑
2023
Annual accounts 2023642 k €↓
2023
Name changeDEVANTHINIC
2022
Annual accounts 20221,8 M €↑
2021
Annual accounts 2021825,1 k €↑
2021
Name changeDevanthinic Pharma
2020
Annual accounts 2020691,5 k €↑
2019
Annual accounts 2019407,3 k €↓
2018
Annual accounts 20181,3 M €↑
2017
Annual accounts 201767,1 k €↑
2016
Annual accounts 201641,7 k €↑
2015
Annual accounts 201515,7 k €
16/12/2014
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

DEVANTHINIC PHARMA

Overview

What does DEVANTHINIC PHARMA do?

Trend over 11 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline